Chinese Starbucks Rival Luckin Coffee Starts Work on U.S. IPO
(Bloomberg) -- Luckin Coffee, the ambitious Chinese startup rolling out thousands of stores to take on Starbucks Corp., is beginning preparations for a U.S. initial public offering that could raise around $300 million, people with knowledge of the matter said.
The company is working with Credit Suisse Group AG on the deal, which could take place as soon as the second quarter, according to the people. Luckin could add more banks at a later stage, the people said, asking not to be identified because the information is private.
Luckin is spending heavily to roll out 2,500 additional stores this year, after the company opened about 2,000 outlets in 2018, its first year of operation. It's putting pressure on Starbucks, which has made China into its fastest-growing market and the second-biggest among the over 50 countries it operates in.
The Chinese firm is hoping its focus on convenience and affordability will lure urban office workers who don't need the big plush spaces offered by the U.S. giant. Luckin's outlets are cashless and designed for fast pick-up as well as delivery. Starbucks, which opened its first store in China 20 years ago, only launched delivery in partnership with Alibaba Group Holding Ltd. in August.
Luckin, most recently valued at $2.2 billion, has attracted funding from investors including Singapore sovereign wealth fund GIC Pte and China International Capital Corp. It has also inked a partnership with internet giant Tencent Holdings Ltd.
Read more: China's Coffee Unicorn Is Burning Millions to Overtake Starbucks
Plans for the IPO are at an early stage, and details of the transaction could change, the people said. Representatives for Luckin and Credit Suisse declined to comment.
--With assistance from Manuel Baigorri and Daniela Wei.
To contact the reporters on this story: Vinicy Chan in Hong Kong at vchan91@bloomberg.net;Crystal Tse in Hong Kong at ctse44@bloomberg.net
To contact the editors responsible for this story: Ben Scent at bscent@bloomberg.net, Timothy Sifert
©2019 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.